MARKET

TEVA

TEVA

Teva Pharm Ind
NYSE

Real-time Quotes | Nasdaq Last Sale

8.51
-0.13
-1.50%
After Hours: 8.47 -0.04 -0.47% 19:44 01/21 EST
OPEN
8.60
PREV CLOSE
8.64
HIGH
8.72
LOW
8.45
VOLUME
8.55M
TURNOVER
--
52 WEEK HIGH
13.30
52 WEEK LOW
7.73
MARKET CAP
9.39B
P/E (TTM)
12.96
1D
5D
1M
3M
1Y
5Y
10 Best Stocks to Buy Today According to Value Investor David Abrams
In this piece, we will take a look at the 10 best stocks to buy today according to value investor David Abrams. If you want to take a look only at the top five stocks in this list then head on over to 5 Best Stocks to Buy Today According to Value Investor ...
Insider Monkey · 3d ago
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022
TEL AVIV, Israel, January 18, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2021 financial results, as well as on its financial guidance for 2022, on W...
Business Wire · 5d ago
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva Pharmaceutical Industries Limited ( NYSE:TEVA ) shareholders should be happy to see the share price up 12% in the...
Simply Wall St. · 6d ago
Hedge Funds Are Avoiding Teva Pharmaceutical Industries (TEVA)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds...
Insider Monkey · 01/14 17:22
3 Generic Drug Stocks to Watch Amid Stabilizing Pricing Pressure
Zacks.com · 01/04 00:52
Zacks Industry Outlook Highlights: Dr. Reddy's Laboratories, Teva Pharmaceutical and Amphastar Pharmaceuticals
Zacks.com · 01/04 00:51
Hot Stocks: Cruise warning; TEVA found liable; PRDS skyrockets; RELL hits high; IMRX sets post-IPO low
Wall Street engaged in some light profit-taking on Thursday but, despite the fractional dips, the Dow and S&P 500 remained just off their recent highs. Among the decliners on the
Seekingalpha · 12/30/2021 22:26
Why did Teva Pharmaceutical shares drop today? Opioid litigation loss
Teva Pharmaceutical Industries (NYSE:TEVA) shares have slid ~6% in trading this afternoon after a New York jury found the company guilty of contributing to the prescription opioid epidemic. At its lowest today, shares
Seekingalpha · 12/30/2021 20:43
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TEVA. Analyze the recent business situations of Teva Pharm Ind through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

5.00%Strong Buy
5.00%Buy
85.00%Hold
5.00%Under-perform
0.00%Sell
Analyst Price Target
The average TEVA stock price target is 11.36 with a high estimate of 17.00 and a low estimate of 9.00.
High17.00
Average11.36
Low9.00
Current 8.51
EPS
Actual
Estimate
0.180.360.550.73
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 692
Institutional Holdings: 567.12M
% Owned: 51.42%
Shares Outstanding: 1.10B
TypeInstitutionsShares
Increased
121
30.59M
New
34
3.86M
Decreased
137
62.67M
Sold Out
40
2.14M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.92%
Pharmaceuticals & Medical Research
-1.11%
Key Executives
Non-Executive Chairman/Independent Director
Sol Barer
President/Chief Executive Officer/Director
Kaare Schultz
Chief Financial Officer/Executive Vice President
Eliyahu Kalif
Chief Human Resource Officer/Executive Vice President
Galia Inbar
Executive Vice President
Richard Daniell
Executive Vice President
Sven Dethlefs
Executive Vice President
Eric Drape
Executive Vice President
Hafrun Fridriksdottir
Executive Vice President
Mark Sabag
Executive Vice President
Eli Shani
Executive Vice President
David Stark
Senior Vice President/Chief Accounting Officer
Amir Weiss
Independent Director
Rosemary Crane
Independent Director
Amir Elstein
Independent Director
Jean-Michel Halfon
Independent Director
Gerald Lieberman
Independent Director
Roberto Mignone
Independent Director
Perry Nisen
Independent Director
Nechemia Peres
Independent Director
Ronit Satchi-Fainaro
Independent Director
Janet Vergis
Independent Director
Tal Zvi Zaks
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.072
11/27/2017
08/04/2017
Dividend USD 0.072
08/25/2017
05/16/2017
Dividend USD 0.289
06/01/2017
03/16/2017
Dividend USD 0.289
02/28/2017
11/17/2016
Dividend USD 0.289
12/01/2016
08/08/2016
Dividend USD 0.289
08/18/2016
05/11/2016
Dividend USD 0.289
05/20/2016
02/16/2016
Dividend USD 0.289
02/25/2016
11/02/2015
Dividend USD 0.289
11/13/2015
07/31/2015
Dividend USD 0.289
08/18/2015
05/05/2015
Dividend USD 0.289
05/15/2015
02/20/2015
Dividend USD 0.294
02/17/2015
11/18/2014
Dividend USD 0.27
11/13/2014
08/25/2014
Dividend USD 0.291
08/19/2014
05/20/2014
Dividend USD 0.298
05/16/2014
03/05/2014
Dividend USD 0.293
02/20/2014
11/21/2013
Dividend USD 0.278
11/18/2013
08/21/2013
Dividend USD 0.274
08/16/2013
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Webull offers kinds of Teva Pharmaceutical Industries Ltd (ADR) stock information, including NYSE:TEVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TEVA stock methods without spending real money on the virtual paper trading platform.